A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)

Clinical trial NCT01358344 · COMPLETED

Trial details

NCT number: NCT01358344
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2010-08-01
Primary completion: 2010-12-01
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.